Peutz-Jeghers syndrome screening

Revision as of 19:48, 9 September 2015 by Mohamad Alkateb (talk | contribs)
Jump to navigation Jump to search

Peutz-Jeghers syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Peutz-Jeghers syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Peutz-Jeghers syndrome screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Peutz-Jeghers syndrome screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Peutz-Jeghers syndrome screening

CDC on Peutz-Jeghers syndrome screening

Peutz-Jeghers syndrome screening in the news

Blogs on Peutz-Jeghers syndrome screening

Directions to Hospitals Treating Peutz-Jeghers syndrome

Risk calculators and risk factors for Peutz-Jeghers syndrome screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]

Overview

Screening for cancerous lesions by small intestine radiography, esophagogastroduodenoscopy (EGD), colonoscopy, pancreatic ultrasound, pelvic ultrasound, mammography, and Papanicolaou (Pap) test are recommended among patients with Peutz-Jeghers syndrome.

Screening

Patients who are at risk of developing Peutz-Jeghers syndrome are screened for the locations of the hamartomas by:

Screening for cancerous lesions among patients with Peutz-Jeghers syndrome include the following:

  • Small intestine radiography (every 2 years)
  • Esophagogastroduodenoscopy (every 2 years)
  • Colonoscopy every 2 years
  • Pancreatic ultrasound (annually)
  • Endoscopic ultrasound
  • Magnetic resonance cholangiopancreatography (MRCP)
  • Abdominal CT
  • Pelvic ultrasound (annually)
  • Testicular ultrasound (annually)
  • Mammography at ages 25, 30, 35, and 38 years, then every 2 years until age 50 years, then annually
  • Cervical Papanicolaou (Pap) test (annually).
  • Annual physical examination that includes evaluation of the breasts, abdomen, pelvis, and testes should be done by a physician
  • Annual complete blood count to check for anemia should be done


References

Template:Digestive system neoplasia


Template:WH Template:WS